D'ANGELO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 1.251
EU - Europa 749
AS - Asia 189
OC - Oceania 3
SA - Sud America 3
Totale 2.195
Nazione #
US - Stati Uniti d'America 1.247
IE - Irlanda 364
IT - Italia 147
CN - Cina 139
DE - Germania 67
SE - Svezia 55
UA - Ucraina 41
TR - Turchia 24
GB - Regno Unito 23
FR - Francia 17
VN - Vietnam 14
BE - Belgio 13
FI - Finlandia 7
IN - India 6
NL - Olanda 4
AU - Australia 3
CA - Canada 3
RO - Romania 3
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
HK - Hong Kong 1
KR - Corea 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
SG - Singapore 1
SI - Slovenia 1
Totale 2.195
Città #
Chandler 408
Dublin 361
Jacksonville 175
New York 64
Ashburn 48
Lawrence 41
Princeton 41
Beijing 40
Hangzhou 38
L'aquila 37
Ann Arbor 36
Wilmington 33
Bremen 24
Nanjing 21
San Mateo 19
Woodbridge 17
Boardman 15
Los Angeles 15
Des Moines 14
Dong Ket 14
Brussels 13
Izmir 13
Aquila 11
Cernusco Sul Naviglio 10
L’Aquila 8
Milan 8
Redmond 8
West Jordan 8
Rome 7
Teramo 7
Hanover 6
Pune 6
Cedar Knolls 5
Dearborn 5
Houston 5
Mascalucia 5
Shenyang 5
Washington 5
Nanchang 4
Rotterdam 4
Seattle 4
Basciano 3
Dallas 3
Helsinki 3
Kunming 3
Menlo Park 3
Mountain View 3
Norwalk 3
San Francisco 3
Toronto 3
Cambridge 2
Casoria 2
Changchun 2
Citta Sant'angelo 2
Fairfield 2
Frankfurt am Main 2
Genova 2
Grafing 2
Guangzhou 2
Hebei 2
Hefei 2
Isernia 2
Jinan 2
London 2
Ningbo 2
Redwood City 2
Shanghai 2
Strasbourg 2
Taizhou 2
Tampa 2
Tianjin 2
Aosta 1
Atlanta 1
Avezzano 1
Brisbane 1
Campobasso 1
Campodipietra 1
Casamassima 1
Central 1
Changsha 1
Chieti 1
Cittaducale 1
Edinburgh 1
Falls Church 1
Fremont 1
Fuzhou 1
Istanbul 1
Jiaxing 1
Kuala Lumpur 1
Lanzhou 1
Lappeenranta 1
Lisbon 1
Ljubljana 1
Luxembourg 1
Melbourne 1
Naples 1
Panama City 1
Quanzhou 1
Quzhou 1
Riccia 1
Totale 1.706
Nome #
CXCR1/2 pathways in paclitaxel-induced neuropathic pain 128
Role of PPAR transcription factors in the energetic metabolic switch occurring during neurogenesis 97
Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis 96
Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium 93
Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models 82
YAP/TAZ mechano-transduction as the underlying mechanism of neuronal differentiation induced by reduced graphene oxide. 81
Flavopiridol: An old drug with new perspectives? Implication for development of new drugs. 79
Local anesthetics counteract cell proliferation and migration of human triple-negative breast cancer and melanoma cells. 75
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 72
Probiotic DSF counteracts chemotherapy induced neuropathic pain 72
Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin 68
Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics 55
APTAMER-DRIVEN TOXIN GENE DELIVERY IN U87 MODEL GLIOBLASTOMA CELLS 54
PPARs and Energy Metabolism Adaptation during Neurogenesis and Neuronal Maturation 53
Neuronal Cells Rearrangement During Aging and Neurodegenerative Disease: Metabolism, Oxidative Stress and Organelles Dynamic 48
The emerging role of probiotics in neurodegenerative diseases: New hope for Parkinson's disease? 48
Neuroprotective activities of bacopa, lycopene, astaxanthin, and vitamin B12 combination on oxidative stress-dependent neuronal death 48
Olive leaf extract impairs mitochondria by pro-oxidant activity in MDA-MB-231 and OVCAR-3 cancer cells 47
A State-of-the-Art of Functional Scaffolds for 3D Nervous Tissue Regeneration 47
The great escape: The power of cancer stem cells to evade programmed cell death 47
Neuroprotective potential of choline alfoscerate against β-amyloid injury: Involvement of neurotrophic signals 46
An Update on Graphene-Based Nanomaterials for Neural Growth and Central Nervous System Regeneration 46
Theranostic Nanomedicine for Malignant Gliomas 45
Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain 44
Lifestyle and food habits impact on chronic diseases: Roles of PPARs 44
Effects of agalsidase-β administration on vascular function and blood pressure in familial Anderson–Fabry disease 44
Pparα-selective antagonist gw6471 inhibits cell growth in breast cancer stem cells inducing energy imbalance and metabolic stress 44
NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes 43
The Role of Stiffness in Cell Reprogramming: A Potential Role for Biomaterials in Inducing Tissue Regeneration 42
Micrornas dysregulation and mitochondrial dysfunction in neurodegenerative diseases 42
PPARγ and cognitive performance 41
Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders 41
Environmentally relevant concentrations of triclocarban affect morphological traits and melanogenesis in zebrafish larvae 39
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease 38
S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson's Disease In Vitro Model 36
Insights into the effects of mesenchymal stem cell-derived secretome in Parkinson’s disease 33
L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease 31
Cxcr1/2 inhibitor ladarixin ameliorates the insulin resistance of 3t3-l1 adipocytes by inhibiting inflammation and improving insulin signaling 31
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 30
An experimental approach to study the effects of realistic environmental mixture of Linuron and propamocarb on Zebrafish synaptogenesis 29
Current and experimental therapeutics for Fabry disease 28
Sublethal exposure to propylparaben leads to lipid metabolism impairment in zebrafish early-life stages 20
Looking for in vitro models for retinal diseases 18
Neurotrophic factor-based pharmacological approaches in neurological disorders 14
Therapeutic advances in neural regeneration for Huntington's disease 10
Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson's disease models 10
Effects of chronic oral probiotic treatment in paclitaxel-induced neuropathic pain 9
Early-life exposure to environmentally relevant concentrations of triclocarban impairs ocular development in zebrafish larvae 9
Therapeutic potential of saffron in brain disorders: From bench to bedside 4
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease 3
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain 3
Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut 3
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 2
Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice 2
Totale 2.314
Categoria #
all - tutte 9.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 0 24
2019/2020280 25 2 24 8 5 56 36 13 35 22 11 43
2020/2021313 39 20 1 21 29 21 48 5 37 15 52 25
2021/2022257 6 3 27 26 10 7 7 26 28 3 12 102
2022/20231.021 61 92 26 147 65 103 3 55 420 7 33 9
2023/2024275 24 14 20 16 27 120 6 20 0 28 0 0
Totale 2.314